ArticleJPRAS open2026
A premixed calcium hydroxylapatite/carboxymethylcellulose-hyaluronic acid hybrid filler for skin quality.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hybrid injectable approaches combining calcium hydroxylapatite/carboxymethylcellulose with hyaluronic acid gels may improve both facial contour and skin quality. Methods: We retrospectively reviewed 12 women treated with a premixed hybrid filler injected in the subdermal plane across the mid- and lower-face. Outcomes were assessed at baseline and 4 months using the Merz Aesthetic Scales for mid- and lower-face aging severity, the Lemperle Wrinkle Severity Scale (cheek wrinkles), and a 5-point Global Aesthetic Improvement Scale for patient-reported "skin glow." Results: All Merz domains and cheek wrinkle severity improved at 4 months (cheek wrinkles, Conclusions: In this retrospective case series, the premixed hybrid filler was well tolerated and was associated with improvement in mid- and lower-face aging severity and patient-perceived skin glow at 4 months. Level of evidence: IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.